The cancer-associated thrombosis-causing clinical characteristics study in Japan

Study of explorsion of the cause of cancer- and cancer therapy-associated thrombosis and development of its predicting markers - CATCH-J study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038762

Enrollment

2500

Registered

2020-06-01

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, Gastrointestinal cancer, Pancreatic cancer,Genicological cancer, Symptomatic malignant myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lung cancer, Gastrointestinal cancer, Pancreatic cancer,Genicological cancer, Symptomatic malignant myeloma

Exclusion criteria

Exclusion criteria: 1) Subject's disagreement with written informed consent 2) Other conditions determined inappropriate by the responsible/sub doctor

Design outcomes

Primary

Measure	Time frame
thrombosis (at the time of registration and 6-month follow-up)	—

Secondary

Measure	Time frame
thrombosis-related tests	—

Countries

Japan

Contacts

Public ContactManabu Minami

Kyoto University Hospital Institute for Advancement of Clinical and Translational Science

mminami@kuhp.kyoto-u.ac.jp075-751-4735

Outcome results